Cargando…
1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol
The title compound, C(11)H(12)O(2), is an intermediate in the synthesis of Varenicline, a nicotinic receptor partial agonist used to treat smoking addiction. In the crystal structure, there is an intramolecular O—H⋯O hydrogen bond that generates an S(5) ring motif. Intermolecular O—H⋯O hydrogen b...
Autores principales: | Xu, Jian, Xu, Hao, Quan, Ji-cai, Sha, Fei, Yao, Cheng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967988/ https://www.ncbi.nlm.nih.gov/pubmed/21581717 http://dx.doi.org/10.1107/S1600536808041068 |
Ejemplares similares
-
rac-1,2,3,4-Tetrahydro-1,4-methanoanthracene-6,7-dicarbonitrile
por: Chen, Kew-Yu, et al.
Publicado: (2011) -
(6RS,9SR)-6,7-Dibromo-1,2,3,4-tetrahydro-1,4-methanoanthracene
por: Chen, Kew-Yu, et al.
Publicado: (2011) -
(1R,4S)-7,8-Dichloro-1,2,3,4-tetrahydro-1,11,11-trimethyl-1,4-methanophenazine
por: Crundwell, Guy, et al.
Publicado: (2010) -
rac-3,4-trans-Dichloro-1,2,3,4-tetrahydro-2-naphthyl acetate
por: Şahin, Ertan, et al.
Publicado: (2008) -
2-(1,2,3,4-Tetrahydro-1-naphthyl)imidazolium chloride monohydrate
por: Bruni, Bruno, et al.
Publicado: (2010)